LOBE — Lobe Sciences Cashflow Statement
0.000.00%
- CA$3.43m
- CA$3.79m
- CA$0.84m
- 28
- 12
- 28
- 12
Annual cashflow statement for Lobe Sciences, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.754 | -3.44 | -22.8 | -12.3 | -4.71 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -1.34 | 1.67 | 17.6 | 8.66 | 1.43 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.323 | -0.019 | 0.185 | 0.848 | 1.52 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Cash from Operating Activities | -2.04 | -1.22 | -5.04 | -2.73 | -1.72 |
Capital Expenditures | 0 | — | -0.137 | 0 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.464 | 0.199 | 1.2 | 1.74 | 0 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.464 | 0.199 | 1.07 | 1.74 | 0 |
Financing Cash Flow Items | -0.683 | 0.003 | -0.198 | -0.043 | -0.102 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.475 | 0.719 | 4.92 | 0.753 | 0.95 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.97 | -0.341 | 0.97 | -0.234 | -0.767 |